NASDAQ: NGEN
Nervgen Pharma Corp Earnings Dates, Reports, Calls

Nervgen Pharma earnings were -$17.0M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest NGEN earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$4.5M, down 159.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NGEN reported annual earnings of -$32.3M, with 95.7% growth.

NGEN earnings history

Current Revenue
$0.0
Current Earnings
-$17.1M
Current Profit Margin
0%

NGEN Return on Equity

Current Company
-95.2%
Current Industry
-19.8%
Current Market
35.9%
NGEN's Return on Equity (-138.6%)... subscribe to Premium to read more.
High Return on Equity Performance

NGEN Return on Assets

Current Company
-44.3%
Current Industry
-8.8%
NGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NGEN announces earnings.

NGEN Return on Capital Employed

Current Company
-55.48%
Current Industry
-4.2%

NGEN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NGEN-$16.94M-$16.98MN/A-$0.23
ACIUN/A-$44.02MN/A-$0.49
LCTX-$2.28M$1.75MN/A$0.01
YARW-$21.14M-$21.15MN/A-$13.44
CYPH$1.26M-$877.00kN/A$0.59

Nervgen Pharma Earnings Reports & History FAQ

What were Nervgen Pharma's earnings last quarter?

On NGEN's earnings call on Nov 16, 2026, Nervgen Pharma (NASDAQ: NGEN) reported Q3 2026 earnings per share (EPS) of -$0.04, up 2.33% year over year. Total NGEN earnings for the quarter were -$4.50 million. In the same quarter last year, Nervgen Pharma's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Nervgen Pharma stock.

Is Nervgen Pharma profitable or losing money?

As of the last Nervgen Pharma earnings report, Nervgen Pharma is currently losing money. Nervgen Pharma's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$17.06 million, a 7.58% decrease year over year.

What was NGEN's earnings growth in the past year?

As of Nervgen Pharma's earnings date in Nov 16, 2026, Nervgen Pharma's earnings has grown year over year. NGEN earnings in the past year totalled -$16.98 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.